Live feed
Filing
SC 13G/A
SC 13G/A0000902219-18-000201·Syndax Pharmaceuticals Inc
Schedule 13G ownership disclosure
Syndax Pharmaceuticals Inc
Security class unavailable · CUSIP: 87164F105
Event date: 2017-12-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,414,590
- Percent of class
- 14.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-18-000201
- Form type
- SC 13G/A
- Filer
- Syndax Pharmaceuticals Inc
- CIK
- CIK 1395937
- Filed
- Feb 08, 2018
- Reporting period
- Dec 29, 2017
- Description
- Schedule 13G beneficial ownership